At close: December 20 at 4:54:06 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-5,562.5910
-3,127.7350
-8,414.4360
-4,465.2030
-7,444.5890
Investing Cash Flow
--
-1,777.6770
--
-120.2490
-650.4460
Financing Cash Flow
6,038.0000
4,742.0000
7,768.0000
-2,000.0000
13,126.5000
End Cash Position
519.4580
149.5220
313.6570
960.0930
7,545.5450
Capital Expenditure
--
-1,777.6770
--
-120.2490
-650.4460
Issuance of Capital Stock
--
--
5,500.0000
--
11,126.5000
Issuance of Debt
--
2,242.0000
2,268.0000
--
2,000.0000
Repayment of Debt
--
--
--
-2,000.0000
--
Free Cash Flow
-5,562.5910
-4,905.4120
-8,414.4360
-4,585.4520
-8,095.0350
12/31/2020 - 3/12/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MODTX.ST Modus Therapeutics Holding AB (publ)
1.9000
-4.76%
ABERA.ST Abera Bioscience AB
4.1500
+3.75%
KDEV.ST Karolinska Development AB (publ)
1.0080
-1.18%
DIABIO.ST Diagonal Bio AB (publ)
0.0258
+5.31%
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
CRNA.OL Circio Holding ASA
0.7080
-3.28%
FLUI.ST Fluicell AB (publ)
0.0412
-1.90%
ATORX.ST Alligator Bioscience AB (publ)
0.2665
+3.50%
ISOFOL.ST Isofol Medical AB (publ)
2.4050
-3.80%
ONCO.ST Oncopeptides AB (publ)
1.5080
-1.69%